Vanda Pharmaceuticals Inc. Contracts & Agreements

119 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Restricted Stock Unit Award Agreement for Senior Management under the Amended and Restated 2016 Equity Incentive Plan
Equity Distribution Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2025
Amendment No. 2 to the Rights Agreement, dated as of August 7, 2024, by and between Vanda Pharmaceuticals Inc. and Equiniti Trust Company, LLC, as rights agent
Registration Rights Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2024
Amendment No. 1 to the Rights Agreement, dated as of May 3, 2024, by and between Vanda Pharmaceuticals Inc. and Equiniti Trust Company, LLC, as rights agent
Registration Rights Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2024
Rights Agreement, dated as of April 17, 2024, by and between Vanda Pharmaceuticals Inc. and Equiniti Trust Company, LLC as rights agent
Registration Rights Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2024
Asset Purchase Agreement, dated December 7, 2023, by and between Actelion Pharmaceuticals Ltd. and the registrant
Purchase Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2024
Form of Restricted Stock Unit Award Agreement for U.S. Employees under Amended and Restated 2016 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2023
Form of Restricted Stock Unit Award Agreement for Senior Management under Amended and Restated 2016 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2023
Form of Restricted Stock Unit Award Agreement for Outside Directors under Amended and Restated 2016 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2023
Form of Restricted Stock Unit Award Agreement for UK Employees under the UK Sub Plan under Amended and Restated 2016 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2023
Form of Notice of Stock Option Grant and Stock Option Agreement for U.S. Employees under Amended and Restated 2016 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2023
Form of Notice of Stock Option Grant and Stock Option Agreement for Senior Management under Amended and Restated 2016 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2023
Form of Notice of Stock Option Grant and Stock Option Agreement for Outside Directors under Amended and Restated 2016 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2023
Form of Notice of Stock Option Grant and Stock Option Agreement for UK Employees under the UK Sub Plan under Amended and Restated 2016 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2023
Form of Restricted Stock Unit Award Agreement for Executive Officers under the Amended and Restated 2016 Equity Incentive Plan
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2023
Form of Restricted Stock Unit Award Agreement for Employees under the Amended and Restated 2016 Equity Incentive Plan
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2023
License Agreement, dated January 13, 2022, by and among MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, Impax Laboratories LLC and the registrant
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2022
Description of Securities of the registrant
Vanda Pharmaceuticals Inc.
Biotechnology
2022
Manufacturing Agreement, dated January 24, 2014, by and between Patheon Pharmaceuticals Inc. and the registrant (relating to HETLIOZ
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2022
Manufacturing Agreement, dated May 6, 2016, by and between Patheon Pharmaceuticals Inc. and the registrant (relating to Fanapt
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2022
Fifth Amendment to Lease Agreement, dated April 11, 2019
Lease Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2021
Sixth Amendment to Lease Agreement, dated May 7, 2020, by and between Square 54 Office Owner LLC and the registrant
Lease Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2021
Amended and Restated Employment Agreement, dated July 27, 2020, by and between Kevin Moran and the registrant
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DC
2020
Amended and Restated Employment Agreement, dated May 5, 2020, by and between Kevin Moran and the registrant
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DC
2020
Employment Agreement, dated July 3, 2019, by and between Aranthan "AJ" Jones II and the registrant
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DC
2019
Employment Agreement, dated August 5, 2019, by and between Joakim Wijkstrom and the registrant
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DC
2019
Employment Agreement, dated August 13, 2018, by and between Timothy Williams and the registrant
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DC
2018
Amendment to Rights Agreement, dated June 1, 2018, between the Company and American Stock Transfer and Trust Company, as Rights Agent
Vanda Pharmaceuticals Inc.
Biotechnology
2018
Third Amendment to Lease Agreement, dated March 28, 2018, by and between Square 54 Office Owner LLC and the registrant
Lease Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2018
Fourth Amendment to Lease Agreement, dated March 29, 2018, by and between Square 54 Office Owner LLC and the registrant
Lease Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2018
Amended and Restated Employment Agreement, dated April 30, 2018, by and between Gunther Birznieks and the registrant
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DC
2018
Underwriting Agreement, dated March 15, 2018 by and among the Company, Citigroup Global Markets Inc. and Jefferies LLC, as representatives of the several underwriters named therein
Underwriting Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2018
Employment Agreement, dated June 12, 2009, by and between Gunther Birznieks and the registrant
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2018
CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2017
CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2017
Manufacturing Agreement May 6, 2016 Table of Contents
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2016
AMENDMENT NO. 2 TO LEASE
Lease Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2016
AGREEMENT OF SUBLEASE
Lease Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2016
UK SUB-PLAN TO THE VANDA PHARMACEUTICALS INC. 2006 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2016
UK SUB-PLAN TO THE VANDA PHARMACEUTICALS INC. 2006 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2016
UK SUB-PLAN TO THE VANDA PHARMACEUTICALS INC. 2006 EQUITY INCENTIVE PLAN: NOTICE OF RESTRICTED STOCK UNIT AWARD
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2016
AGREEMENT
Vanda Pharmaceuticals Inc.
Biotechnology
2016
VANDA PHARMACEUTICALS INC. EMPLOYMENT AGREEMENT
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DC
2015
VANDA PHARMACEUTICALS INC. EMPLOYMENT AGREEMENT
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DC
2015
SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASE
Settlement Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2015
CONFIDENTIAL TREATMENT REQUESTED
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2015
CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 1 TO SUBLICENSE AGREEMENT
Vanda Pharmaceuticals Inc.
Biotechnology
2015
CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 2 TO SUBLICENSE AGREEMENT
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2015
CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 3 TO SUBLICENSE AGREEMENT
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2015
STOCK PURCHASE AGREEMENT
Stock Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2015
CONFIDENTIAL TREATMENT REQUESTED
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2015
5,000,000 Shares of Common Stock par value $0.001 750,000 Option Shares Vanda Pharmaceuticals Inc. PURCHASE AGREEMENT
Stock Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2014
CONFIDENTIAL TREATMENT REQUESTED Manufacturing Agreement January 24, 2014 CONFIDENTIAL TREATMENT REQUESTED Table of Contents
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2014
AMENDMENT NO. 1 TO LEASE
Lease Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2014
VANDA PHARMACEUTICALS INC. December 2, 2013
Vanda Pharmaceuticals Inc.
Biotechnology
DC
2014
4,680,000 Shares of Common Stock par value $0.001 702,000 Over-Allotment Shares Vanda Pharmaceuticals Inc. UNDERWRITING AGREEMENT
Underwriting Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2013
VANDA PHARMACEUTICALS INC. EMPLOYMENT AGREEMENT
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DC
2013
TENTH AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2013
VANDA PHARMACEUTICALS INC. September 12, 2012
Vanda Pharmaceuticals Inc.
Biotechnology
DC
2012
LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between ELI LILLY AND COMPANY (an Indiana corporation) and VANDA PHARMACEUTICALS INC. (a Delaware corporation) Dated as...
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
IN
2012
NINTH AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2012
VANDA PHARMACEUTICALS INC. EMPLOYMENT AGREEMENT
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2012
VANDA PHARMACEUTICALS INC. 2006 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2012
VANDA PHARMACEUTICALS INC. 2006 EQUITY INCENTIVE PLAN: NOTICE OF RESTRICTED STOCK UNIT AWARD
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2012
LEASE BETWEEN SQUARE 54 OFFICE OWNER LLC (as Landlord) AND VANDA PHARMACEUTICALS INC. (as Tenant) 2200 Pennsylvania Avenue, N.W. Washington, D.C.
Lease Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2011
VandaPharmaceuticals Inc. EmploymentAgreement
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2011
Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc.
Biotechnology
2011
Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc.
Biotechnology
2011
TAX INDEMNITY AGREEMENT
Vanda Pharmaceuticals Inc.
Biotechnology
2011
The election of two directors to serve as Class I directors until the 2013 Annual Meeting of Stockholders
Vanda Pharmaceuticals Inc.
Biotechnology
2010
AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2010
AMENDED AND RESTATED
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2010
AMENDMENT TO RIGHTS AGREEMENT
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2009
Financial Statements (Unaudited)
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
Financial Statements (Unaudited)
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
Financial Statements (Unaudited)
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
Financial Statements (Unaudited)
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
delays in the completion of our clinical trials
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
delays in the completion of our clinical trials
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
delays in the completion of our clinical trials
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
delays in the completion of our clinical trials
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
delays in the completion of our clinical trials
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
delays in the completion of our clinical trials
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
delays in the completion of our clinical trials
Vanda Pharmaceuticals Inc.
Biotechnology
2009
delays in the completion of our clinical trials
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
delays in the completion of our clinical trials
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
delays in the completion of our clinical trials
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2009
VANDA PHARMACEUTICALS INC.
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2008
delays in the completion of our clinical trials
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2008
FINANCIAL STATEMENTS (UNAUDITED)
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2007
FINANCIAL STATEMENTS (UNAUDITED)
Vanda Pharmaceuticals Inc.
Biotechnology
2007
a failure of our product candidates to be demonstrably safe and effective
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2007
VANDA PHARMACEUTICALS INC.
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2007
VANDA PHARMACEUTICALS INC.
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2007
Vanda Pharmaceuticals Inc. Employment Agreement
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2006
EX-4.1: 2004 SECURITYHOLDER AGREEMENT
Vanda Pharmaceuticals Inc.
Biotechnology
2006
EX-10.2: SUBLICENSE AGREEMENT
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2006
EX-10.3: AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2006
EX-10.4: NDD-094 LICENSE AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2006
EX-1.1: FORM OF UNDERWRITING AGREEMENT
Underwriting Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2006
EX-10.17: FORM OF INCENTIVE PLAN
Bonus & Incentive Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2006
iloperidone, a compound for the treatment of schizophrenia and bipolar disorder, which we are currently evaluating in a Phase III trial for schizophrenia that we anticipate will...
Vanda Pharmaceuticals Inc.
Biotechnology
2006
iloperidone, a compound for the treatment of schizophrenia and bipolar disorder, which we are currently evaluating in a Phase III trial for schizophrenia that we anticipate will...
Vanda Pharmaceuticals Inc.
Biotechnology
2006
EX-10.2: SUBLICENSE AGREEMET
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2006
EX-10.3: AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2006
EX-10.4: NDD-094 LICENSE AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2006
EX-4.1: 2004 SECURITYHOLDERS AGREEMENT
Vanda Pharmaceuticals Inc.
Biotechnology
2005
EX-4.2: CLASS A COMMON STOCK PURCHASE WARRANT
Warrant Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2005
EX-4.3: CLASS A COMMON STOCK PURCHASE WARRANT
Warrant Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2005
EX-10.1: SECOND AMENDED AND RESTATED MANAGEMENT EQUITY PLAN
Vanda Pharmaceuticals Inc.
Biotechnology
2005
EX-10.7: LEASE AGREEMENT
Lease Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2005
EX-10.8: AMENDMENT TO LEASE AGREEMENT
Lease Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2005
EX-10.9: LEASE AGREEMENT
Lease Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2005
EX-10.10: SUMMARY PLAN DESCRIPTION PROVIDED FOR THE 401(K) PROFIT SHARING PLAN & TRUST
Trust Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2005
EX-10.11: FORM OF INDEMNIFICATION AGREEMENT
Indemnification Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2005
EX-10.12: EMPLOYMENT AGREEMENT FORM MIHAEL H. POLYMEROPOULOS
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2005
EX-10.13: EMPLOYMENT AGREEMENT FOR WILLIAM D. CLARK
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2005
EX-10.14: EMPLOYMENT AGREEMENT FOR STEVE SHALLCROSS
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2005
EX-10.15: EMPLOYMENT AGREEMENT FOR DEEPAK PHADKE
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2005
EX-10.16: EMPLOYMENT AGREEMENT FOR THOMAS COPMANN
Employment Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
MD
2005